349 Early safety and efficacy of a phase 1/2 open-label, multi-center trial of SNS-301 added to pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck (SCCHN)
oleh: William Smith, Jean Campbell, Timothy Panella, Dong Shin, Marie-Louise Fjaellskog, John Celebi, Alice Drumheller, Robert Pierce, Michael Guarino
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.